Sarepta Therapeutics (SRPT) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,234.00 |
| Dec 31, 2025 | -721.00 |
| Sep 30, 2025 | 2,067.00 |
| Jun 30, 2025 | 2,380.00 |
| Mar 31, 2025 | 3,218.00 |
| Dec 31, 2024 | 5,425.00 |
| Sep 30, 2024 | 4,361.00 |
| Jun 30, 2024 | 3,458.00 |
| Mar 31, 2024 | 1,977.00 |
| Dec 31, 2023 | 1,717.00 |
| Sep 30, 2023 | 569.00 |
| Jun 30, 2023 | -227.00 |
| Mar 31, 2023 | -952.00 |
| Dec 31, 2022 | -348.00 |
| Sep 30, 2022 | 2,107.00 |
| Jun 30, 2022 | 4,199.00 |
| Mar 31, 2022 | 4,772.00 |
| Dec 31, 2021 | 5,139.00 |
| Sep 30, 2021 | 6,403.00 |
| Jun 30, 2021 | 14,103.00 |
| Mar 31, 2021 | 9,189.00 |
| Dec 31, 2020 | 10,900.00 |
| Sep 30, 2020 | 9,210.00 |
| Jun 30, 2020 | 6,816.00 |
| Mar 31, 2020 | 3,663.00 |
| Dec 31, 2019 | 241.00 |
| Sep 30, 2019 | -82.00 |
| Jun 30, 2019 | 773.00 |
| Mar 31, 2019 | 1,732.00 |
| Dec 31, 2018 | 671.00 |
| Sep 30, 2018 | 1,448.00 |
| Jun 30, 2018 | 3,443.00 |
| Mar 31, 2018 | 2,659.00 |
| Mar 31, 2017 | 11,842.00 |
| Dec 31, 2016 | 2,663.00 |
| Sep 30, 2016 | -1,736.00 |